Insider Trading activities of Gilead Sciences Inc insiders. , Part 7

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gilead Sciences Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Gilead Sciences Inc since 2005. The reporting company's ticker symbol is GILD. The reporting company's CIK number is 882095.
The total value of stock buying since 2005 is $2,912,783.
The total value of stock sales since 2005 is $2,422,269,920.
The total value of stock option exercises since 2005 is $470,650,194.



Table 2. Detailed insider stock purchases, sales, and option exercises of Gilead Sciences Inc insiders (GILD) , Part 7
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-07-13 Martin John C (Chairman and CEO) Sale 100,000 35.15 3,515,000
2010-07-13 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 369,900
2010-06-08 Martin John C (Chairman and CEO) Sale 100,000 33.83 3,382,500
2010-06-08 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 369,900
2010-06-07 Berg Paul Option Ex 10,000 24.05 240,550
2010-05-19 Berg Paul Option Ex 5,000 11.59 57,950
2010-05-11 Martin John C (Chairman and CEO) Sale 100,000 39.76 3,975,900
2010-05-11 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 369,900
2010-05-04 Wold Olsen Per Buy 12,800 38.59 494,016
2010-05-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 40.00 200,000
2010-05-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 15.27 76,325
2010-04-21 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 11,989 17.08 204,748
2010-04-13 Martin John C (Chairman and CEO) Sale 100,000 46.32 4,631,900
2010-04-13 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 369,900
2010-04-05 Berg Paul Option Ex 100 3.39 338
2010-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 45.79 228,965
2010-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 15.27 76,325
2010-03-09 Martin John C (Chairman and CEO) Sale 100,000 47.44 4,743,700
2010-03-09 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 369,900
2010-03-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,500 47.66 262,102
2010-03-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,500 15.27 83,957
2010-02-24 Bischofberger Norbert W (EVP, R&D and CSO) Sale 53,754 47.49 2,552,562
2010-02-24 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 60,000 16.01 960,600
2010-02-23 Berg Paul Sale 15,000 47.43 711,480
2010-02-23 Berg Paul Option Ex 15,000 7.26 108,900
2010-02-19 Metza Kristen (SVP, Human Resources) Sale 37,500 49.01 1,837,800
2010-02-19 Metza Kristen (SVP, Human Resources) Option Ex 37,500 30.66 1,149,937
2010-02-18 Alton Gregg H (EVP, Corp & Med Affairs) Sale 3,000 49.00 147,000
2010-02-18 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 3,000 15.27 45,795
2010-02-18 Metza Kristen (SVP, Human Resources) Sale 7,900 49.00 387,100
2010-02-18 Metza Kristen (SVP, Human Resources) Option Ex 7,900 28.26 223,254
2010-02-17 Metza Kristen (SVP, Human Resources) Sale 100 49.00 4,900
2010-02-17 Metza Kristen (SVP, Human Resources) Option Ex 100 28.26 2,826
2010-02-09 Martin John C (Chairman and CEO) Sale 100,000 46.37 4,637,300
2010-02-09 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 369,900
2010-02-03 Davignon Etienne Sale 45,000 47.74 2,148,390
2010-02-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,500 48.02 264,115
2010-02-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,500 15.27 83,957
2010-01-27 Alton Gregg H (EVP, Corp & Med Affairs) Sale 500 47.00 23,500
2010-01-27 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 500 15.27 7,632
2010-01-12 Martin John C (Chairman and CEO) Sale 100,000 44.80 4,480,000
2010-01-12 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 370,100
2010-01-04 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 43.33 216,665
2010-01-04 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 5,000 15.27 76,325
2009-12-24 Milligan John F (President and COO) Option Ex 17,748 4.83 85,687
2009-12-08 Martin John C (Chairman and CEO) Sale 100,000 46.16 4,616,300
2009-12-08 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 370,300
2009-12-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 8,000 45.75 366,000
2009-12-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 8,000 17.50 139,976
2009-12-01 Young Kevin (EVP, Commercial Operations) Sale 75,000 45.80 3,435,150
2009-12-01 Young Kevin (EVP, Commercial Operations) Option Ex 75,000 16.84 1,263,150
2009-12-01 Milligan John F (President and COO) Sale 60,000 46.03 2,761,560
2009-12-01 Milligan John F (President and COO) Option Ex 60,000 8.22 493,139
2009-11-27 Berg Paul Sale 15,000 46.00 690,000
2009-11-27 Berg Paul Option Ex 15,000 7.26 108,900
2009-11-12 Bischofberger Norbert W (EVP, R&D and CSO) Sale 49,920 47.08 2,350,083
2009-11-12 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 30,000 16.01 480,300
2009-11-10 Martin John C (Chairman and CEO) Sale 100,000 46.88 4,688,500
2009-11-10 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 370,300
2009-11-05 Alton Gregg H (EVP, Corp & Med Affairs) Sale 5,000 45.00 225,000
2009-11-05 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 4,584 13.22 60,600
2009-11-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 3,000 42.82 128,460
2009-11-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 3,000 8.94 26,829
2009-10-29 Berg Paul Sale 15,000 42.57 638,550
2009-10-29 Berg Paul Option Ex 15,000 7.26 108,900
2009-10-13 Martin John C (Chairman and CEO) Sale 100,000 45.40 4,540,100
2009-10-13 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 370,300
2009-10-05 Young Kevin (EVP, Commercial Operations) Sale 30,000 44.70 1,341,120
2009-10-05 Young Kevin (EVP, Commercial Operations) Option Ex 30,000 16.84 505,259
2009-10-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 8,000 46.20 369,600
2009-10-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 3,000 8.94 26,829
2009-09-24 Berg Paul Sale 15,000 45.77 686,550
2009-09-24 Berg Paul Option Ex 15,000 7.26 108,900
2009-09-08 Martin John C (Chairman and CEO) Sale 100,000 46.68 4,667,900
2009-09-08 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 370,300
2009-09-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 8,000 44.95 359,640
2009-09-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 3,000 8.94 26,829
2009-09-01 Milligan John F (President and COO) Sale 60,000 45.46 2,727,660
2009-09-01 Milligan John F (President and COO) Option Ex 60,000 8.22 493,139
2009-08-27 Berg Paul Sale 15,000 45.76 686,400
2009-08-27 Berg Paul Option Ex 15,000 7.26 108,900
2009-08-21 Wilson Gayle E Sale 78,400 46.06 3,611,104
2009-08-21 Wilson Gayle E Option Ex 78,400 8.35 654,796
2009-08-11 Martin John C (Chairman and CEO) Sale 100,000 45.44 4,543,700
2009-08-11 Martin John C (Chairman and CEO) Option Ex 100,000 3.70 370,300
2009-08-07 Moore Gordon Earle Sale 110,817 46.07 5,104,895
2009-08-07 Moore Gordon Earle Option Ex 144,000 3.38 487,152
2009-08-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 8,000 48.99 391,920
2009-08-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 3,000 8.94 26,829
2009-07-30 Berg Paul Sale 15,000 49.99 749,850
2009-07-30 Berg Paul Option Ex 15,000 6.48 97,185
2009-07-30 Denny James M Sale 76,500 49.89 3,816,738
2009-07-30 Denny James M Option Ex 90,000 17.57 1,581,030
2009-07-28 Metza Kristen (SVP, Human Resources) Sale 8,000 49.00 392,000
2009-07-28 Metza Kristen (SVP, Human Resources) Option Ex 8,000 30.66 245,320
2009-07-24 Hills Carla A Buy 2,500 48.28 120,700
2009-07-24 Bischofberger Norbert W (EVP, R&D and CSO) Sale 180,448 48.00 8,661,323
2009-07-24 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 140,000 16.01 2,241,400
2009-07-14 Martin John C (Chairman and CEO) Sale 100,000 45.01 4,501,300
2009-07-14 Martin John C (Chairman and CEO) Option Ex 100,000 3.65 364,900
2009-07-09 Young Kevin (EVP, Commercial Operations) Sale 30,000 44.63 1,338,990
2009-07-09 Young Kevin (EVP, Commercial Operations) Option Ex 30,000 16.84 505,259
2009-07-01 Alton Gregg H (SVP and Secretary) Sale 8,000 47.09 376,720
2009-07-01 Alton Gregg H (SVP and Secretary) Option Ex 3,000 8.94 26,829
2009-06-25 Berg Paul Sale 15,000 46.13 691,950
2009-06-25 Berg Paul Option Ex 15,000 5.70 85,455
2009-06-09 Martin John C (Chairman and CEO) Sale 100,000 44.37 4,436,500
2009-06-09 Martin John C (Chairman and CEO) Option Ex 100,000 3.65 364,900
2009-06-03 Alton Gregg H (SVP, General Counsel) Sale 5,000 45.00 225,000
2009-06-01 Alton Gregg H (SVP, General Counsel) Sale 3,000 43.15 129,450
2009-06-01 Alton Gregg H (SVP, General Counsel) Option Ex 3,000 8.94 26,829
2009-06-01 Milligan John F (President and COO) Sale 60,000 43.23 2,593,740
2009-06-01 Milligan John F (President and COO) Option Ex 60,000 8.22 493,139
2009-05-28 Berg Paul Sale 15,000 41.54 623,100
2009-05-28 Berg Paul Option Ex 15,000 5.70 85,455
2009-05-21 Bischofberger Norbert W (EVP, R&D and CSO) Sale 130,000 42.63 5,541,510
2009-05-21 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 100,000 16.01 1,601,000
2009-05-12 Martin John C (Chairman and CEO) Sale 100,000 44.63 4,463,300
2009-05-12 Martin John C (Chairman and CEO) Option Ex 100,000 3.65 364,900
2009-05-07 Milligan John F (President and COO) Sale 87,300 44.45 3,880,572
2009-05-07 Milligan John F (President and COO) Option Ex 87,300 8.94 780,723
2009-05-06 Milligan John F (President and COO) Sale 102,248 44.09 4,508,012
2009-05-06 Milligan John F (President and COO) Option Ex 102,248 8.94 914,403
2009-05-05 Milligan John F (President and COO) Sale 199,092 44.49 8,857,802
2009-05-05 Milligan John F (President and COO) Option Ex 199,092 8.94 1,780,479
2009-05-04 Davignon Etienne Option Ex 80,000 3.38 270,640
2009-05-01 Alton Gregg H (SVP, General Counsel) Sale 8,000 45.95 367,600
2009-05-01 Alton Gregg H (SVP, General Counsel) Option Ex 3,000 8.94 26,829
2009-04-30 Berg Paul Sale 15,000 47.37 710,550
2009-04-30 Berg Paul Option Ex 15,000 5.70 85,455
2009-04-30 Denny James M Sale 76,500 46.66 3,569,643
2009-04-30 Denny James M Option Ex 90,000 12.82 1,153,530
2009-04-24 Martin John C (Chairman and CEO) Sale 103,376 45.92 4,747,025
2009-04-24 Martin John C (Chairman and CEO) Option Ex 103,376 3.65 377,115
2009-04-14 Martin John C (Chairman and CEO) Sale 100,000 46.28 4,628,000
2009-04-14 Martin John C (Chairman and CEO) Option Ex 100,000 3.65 364,800
2009-04-03 Young Kevin (EVP, Commercial Operations) Sale 30,000 47.40 1,421,850
2009-04-03 Young Kevin (EVP, Commercial Operations) Option Ex 30,000 16.84 505,259
2009-04-01 Alton Gregg H (SVP, General Counsel) Sale 8,000 44.75 357,976
2009-04-01 Alton Gregg H (SVP, General Counsel) Option Ex 3,000 8.94 26,826
2009-03-26 Berg Paul Sale 15,000 44.20 662,985
2009-03-26 Berg Paul Option Ex 15,000 5.70 85,455
2009-03-10 Martin John C (Chairman and CEO) Sale 100,000 44.07 4,407,300
2009-03-10 Martin John C (Chairman and CEO) Option Ex 100,000 3.65 364,800
2009-03-03 Alton Gregg H (SVP, General Counsel) Sale 5,000 45.00 225,000
2009-03-02 Alton Gregg H (SVP, General Counsel) Option Ex 3,000 8.94 26,826
2009-03-02 Milligan John F (President and COO) Sale 60,000 44.42 2,664,960
2009-03-02 Milligan John F (President and COO) Option Ex 60,000 8.22 493,080
2009-02-26 Berg Paul Sale 15,000 49.51 742,650
2009-02-26 Berg Paul Option Ex 15,000 5.70 85,455

Insider trading activities including stock purchases, stock sales, and option exercises of GILD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gilead Sciences Inc (symbol GILD, CIK number 882095) see the Securities and Exchange Commission (SEC) website.